Sagility India Ltd

Sagility India Ltd

₹ 48.0 0.61%
21 Jan 12:54 p.m.
About

Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]

Key Points

Market Share [1] Headquartered in Bangalore, the company serves only US customers. It holds 1.23% of the U.S. healthcare outsourcing market as of 2023.

Client Segmentation[2]
- Payers: Health insurance companies that finance and reimburse healthcare services. Sagility provides them with services like claims processing, payment integrity, and clinical management.
- Providers: Hospitals, physicians, and diagnostic centers, with services focused on revenue cycle management (RCM) that includes insurance verification, billing, and accounts receivable follow-up.

  • Market Cap 22,484 Cr.
  • Current Price 48.0
  • High / Low 56.4 / 27.0
  • Stock P/E 309
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 2.63 %
  • ROE 1.36 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • Company has high debtors of 204 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Part of BSE IPO

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Jun 2024 Sep 2024
366 387 421
197 316 284
Operating Profit 169 71 137
OPM % 46% 18% 32%
3 2 15
Interest 30 24 23
Depreciation 90 20 35
Profit before tax 52 28 94
Tax % 115% 77% 22%
-8 6 73
EPS in Rs -0.04 0.01 0.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 8m Mar 2023 Mar 2024
281 1,371 1,495
169 891 982
Operating Profit 112 479 512
OPM % 40% 35% 34%
7 47 21
Interest 29 121 116
Depreciation 83 356 357
Profit before tax 8 50 61
Tax % 45% 29% -19%
4 35 73
EPS in Rs 0.02 0.18 0.17
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 107%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 1,919 1,919 4,285 4,679
Reserves 3 23 4,429 5,290
1,520 1,531 1,305 1,146
241 224 257 263
Total Liabilities 3,683 3,697 10,276 11,379
2,969 2,662 2,410 2,405
CWIP 1 0 5 0
Investments 0 0 6,698 7,813
712 1,035 1,163 1,161
Total Assets 3,683 3,697 10,276 11,379

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
11 251 430
-3,171 -103 -33
3,206 -155 -414
Net Cash Flow 46 -7 -17

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
Debtor Days 734 216 204
Inventory Days
Days Payable
Cash Conversion Cycle 734 216 204
Working Capital Days 507 181 178
ROCE % 5% 3%

Shareholding Pattern

Numbers in percentages

Dec 2024
82.39%
3.77%
7.25%
6.59%
No. of Shareholders 2,97,400

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents